---
title: "U.S. stock night trading opened with fluctuations: Cantor Equity Partners rose 16.01% in night trading; Davis Commodities rose 12.24% in night trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/268337968.md"
description: "Cantor Equity Partners rose 16.01% in the night session; Davis Commodities rose 12.24% in the night session; Oriental Rise rose 14.54% in the night session; Cadeler A/S rose 14.43% in the night session; Fibrobiologics rose 11.85% in the night session"
datetime: "2025-12-03T01:20:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/268337968.md)
  - [en](https://longbridge.com/en/news/268337968.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/268337968.md)
generator: "portal-rs"
---

# U.S. stock night trading opened with fluctuations: Cantor Equity Partners rose 16.01% in night trading; Davis Commodities rose 12.24% in night trading

**U.S. Stock Night Market Opening Movements**

Cantor Equity Partners rose 16.01% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Davis Commodities rose 12.24% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

**Top Gainers in the U.S. Stock Night Market**

Oriental Rise rose 14.54% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Cadeler A/S rose 14.43% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Fibrobiologics rose 11.85% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation

### Related Stocks

- [CEP.US](https://longbridge.com/en/quote/CEP.US.md)
- [DTCK.US](https://longbridge.com/en/quote/DTCK.US.md)
- [XXI.US](https://longbridge.com/en/quote/XXI.US.md)
- [DTCKF.US](https://longbridge.com/en/quote/DTCKF.US.md)

## Related News & Research

- [Twenty One Capital targets Berkshire-style buildout of operating businesses around Bitcoin balance sheet](https://longbridge.com/en/news/295523229.md)
- [Twenty One Capital CEO Zagury targets Bitcoin-beating risk-adjusted returns through operating-company strategy](https://longbridge.com/en/news/293912987.md)
- [Linden Advisors LP Sells 165,759 Shares of Cantor Equity Partners, Inc. $CEPO](https://longbridge.com/en/news/279408790.md)
- [Jack Mallers' Twenty One Capital surges after majority holder Tether proposes 3-way merger](https://longbridge.com/en/news/284653815.md)
- [Metaplanet acquires 5,075 BTC, jumps to third largest bitcoin treasury company](https://longbridge.com/en/news/281496390.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**